Menu
Columbus, Ohio – AmplifyBio, a biotechnology contract research organization (CRO) that aims to advance the quality and innovation of human health and advanced therapies, is expanding in the Columbus Region, investing approximately $150 million in a new 350,000-square-foot New Albany facility. With this investment, the company is also creating 263 new jobs across both its new location and its existing West Jefferson location. Hiring for research and development positions will be ongoing through 2022.
AmplifyBio is expanding to meet significant unmet market demand with a large focus on advanced therapies such as cell and gene therapy products. Its new facility at 9885 Innovation Campus Way in New Albany will create 132 new jobs. The company’s existing West Jefferson location on a 30-acre campus at 1425 Plain-City Georgesville Road, which currently has 155 employees, will see the creation of 99 new jobs. In addition, 32 new corporate jobs will be added at a location that is yet to be determined.
“We are excited to expand our presence in the greater Columbus area, and specifically New Albany. We believe the innovation platform we are bringing to the region is synergistic with and reflective of the collaborative environment that I first noticed when I came to Ohio,” commented J. Kelly Ganjei, CEO and President of AmplifyBio. “We are confident that our partners, collaborators and clients see working in this region as an opportunity, and we are convinced that our business model will continue to drive more innovative developers into the area. We are eager to share more details about our development plans which are focused on ways to optimize advanced therapies soon, so stay tuned.”
“We are excited to welcome AmplifyBio to our community’s burgeoning biotech cluster, which is already home to industry leaders such as Amgen,” said City of New Albany Director of Community Development Jennifer Chrysler. “Our four highway interchanges, shovel-ready sites, international business park, triple-feed electric power and state-of-the-art municipal broadband network provide the assets and infrastructure companies need to succeed and scale operations.”
AmplifyBio is leveraging decades of experience in the creation of complex systems in support of advanced therapies using a variety of modern clinical and commercial drug development solutions. They are focused on safety, efficacy, and toxicology testing for best-in-class and advanced therapy drug candidates. AmplifyBio aims to facilitate the industry’s goals of developing scalable products, early in the development lifecycle. In 2021, AmplifyBio raised $200 million in early-stage venture capital investments, which was the second largest venture capital investment in the Columbus Region last year.
“AmplifyBio is working to provide a platform that will help solve the challenges of scaling complex therapies, putting Madison County at the forefront of new advances and technologies in the biotech industry,” said Madison County Chamber of Commerce Executive Director David Kell. “The company’s growth and expansion beyond Madison County is indicative of the collaborative business climate that we have fostered in the Columbus Region, which provides the right atmosphere for groundbreaking research and development.”
From trailblazing innovation to high-tech manufacturing, the Columbus Region is home to one of the most dynamic life science industries in the country. Companies spanning the life science industry have operations focused on R&D, technology, and manufacturing. From Sarepta’s new Gene Therapy Center of Excellence to Battelle’s launch of AmplifyBio, NCH’s launch of Andelyn Biosciences and Forge Biologic’s $130 million series B, the Columbus Region is on the cutting-edge of innovation in the life sciences industry. New Albany is in Franklin County, which is home to an estimated 1,316,756 residents.
“AmplifyBio’s growth is further evidence of the rapidly growing biotech sector throughout the state and Region,” said JobsOhio CEO J.P. Nauseef. “The unique opportunities in research and development that AmplifyBio’s expansion is bringing to the Region, with a mission to advance healthcare for all, is a big win for our workforce and our knowledge economy.”
About AmplifyBio
AmplifyBio is a preclinical contract research organization that combines the strength, knowledge and experience of our partners, and the expertise of our cross-integrated teams to advance translational science, cell and gene therapies and next-generation medicines for the benefit of millions of people around the world. Our facilities include a state-of-the-art fully functional GLP lab with 200,000 sq of space dedicated to drug development including a full complement of pre-clinical models and support services. Learn more at amplify-bio.com.
About New Albany, Ohio
New Albany, Ohio, is an aspirational, welcoming, and collaborative community of 11,000 residents located fifteen miles northeast of Columbus, Ohio’s capital city, and ten miles from the Port Columbus International Airport. Recognized as the best city to live in Ohio and one of “America’s Best 50 Cities to Live”, New Albany is committed to its pillars of lifelong learning, the arts, health, and the environment. New Albany is also home to one of the largest planned international business parks in the Midwest, featuring shovel-ready sites, triple-feed electric power and fiber optic capabilities for companies of all sizes. Learn more at newalbanyohio.org.
